All Articles tagged cost-minimization analysis

• Oncology
  July 18, 2024 EDT
  Cost-Minimization Analysis for Subcutaneous Daratumumab in the Treatment of Newly Diagnosed Multiple Myeloma in Three Gulf Countries
  Anas HamadShereen ElazzazyRuba Y. TahaHani OsmanSana AlblooshiIslam ElkonaissiMustaqeem A. SiddiquiKhalil Al-FarsiMohammed Al LamkiSali EmaraGihan H. Elsisi

  The financial effects of subcutaneous daratumumab vs intravenous daratumumab for treatment of newly diagnosed multiple myeloma in Qatar, Oman and the United Arab Emirates was assessed using a cost-minimization model.

  Abstract
• Ophthalmology
  January 20, 2015 EDT
  Comparing Prednisone and Methotrexate to Off-label Biologic Infliximab for Management of Ocular Uveitis: A Cost-minimization Analysis
  William V. PadulaMiguel Cordero-ComaTaygan YilmazWilliam V. PadulaMichéal J. GallagherJonathan D. Campbell

  To evaluate whether infliximab, a modern off-label biologic, is cost-effective for treating posterior uveitis and panuveitis compared to current standards of care, methotrexate and prednisone.

  Abstract